We expect investors to focus on the sales performance of Assertio Holdings’ ASRT marketed drugs when it reports first-quarter 2022 results on May 9, after the market closes. ASRT’s earnings surpassed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback